Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Medtronic
Cipla
Accenture
Julphar
Teva

Generated: March 20, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Epelsiban

« Back to Dashboard

US Patents for Epelsiban

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Epelsiban ➤ Try a Free Trial Piperazinediones as oxytocin receptor antagonists Glaxo Group Limited (Greenford, Middlesex, GB) ➤ Try a Free Trial
Epelsiban ➤ Try a Free Trial Compounds Glaxo Group Limited (Greenford, Middlesex, GB) ➤ Try a Free Trial
Epelsiban ➤ Try a Free Trial Compounds Glaxo Group Limited (Greenford, Middlesex, GB) ➤ Try a Free Trial
Epelsiban ➤ Try a Free Trial Crystalline forms of (3R, 6R)-3-(2,3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2,6-dimethyl-3-pyridinyl)-2-- (4-morpholinyl)-2-oxoethyl]-6-[(1S)-1-methylpropyl]-2,5-piperazinedione Glaxo Group Limited (Brentford, Middlesex, GB) ➤ Try a Free Trial
Epelsiban ➤ Try a Free Trial Compounds Glaxo Group Limited (Brentford, Middlesex, GB) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Epelsiban

Drugname Country Document Number Estimated Expiration Related US Patent
Epelsiban Argentina 049405 2024-06-23 ➤ Try a Free Trial
Epelsiban Australia 2005256470 2024-06-23 ➤ Try a Free Trial
Epelsiban Brazil PI0512376 2024-06-23 ➤ Try a Free Trial
Epelsiban Canada 2571527 2024-06-23 ➤ Try a Free Trial
Epelsiban China 1972924 2024-06-23 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Cipla
Healthtrust
Moodys
Merck
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.